Lenmeldy is actually a gene therapy utilised to deal with forms of metachromatic leukodystrophy in small children. Lenmeldy works by helping the human body make the ARSA enzyme that will help stop the development of MLD, it does this using the affected person's personal stem cells which have been modified. Lenmeldy is offered as a one-time infusion